The contact activation system and vascular factors as alternative targets for Alzheimer's disease therapy
Abstract Alzheimer's disease (AD) is the most common neurodegenerative disease, affecting millions of people worldwide. Extracellular beta‐amyloid (Aβ) plaques and neurofibrillary tau tangles are classical hallmarks of AD pathology and thus are the prime targets for AD therapeutics. However, ap...
Main Authors: | Pradeep K. Singh, Ana Badimon, Zu‐Lin Chen, Sidney Strickland, Erin H. Norris |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12504 |
Similar Items
-
Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer's patients
by: Pradeep K. Singh, et al.
Published: (2020-06-01) -
Albumin Exchange in Alzheimer's Disease: Might CSF Be an Alternative Route to Plasma?
by: Manuel Menendez-Gonzalez, et al.
Published: (2019-10-01) -
Insoluble Vascular Amyloid Deposits Trigger Disruption of the Neurovascular Unit in Alzheimer’s Disease Brains
by: Luis O. Soto-Rojas, et al.
Published: (2021-04-01) -
A comparative study of the effects of Aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer disease
by: Gerhard Leinenga, et al.
Published: (2021-04-01) -
Protecting P-glycoprotein at the blood–brain barrier from degradation in an Alzheimer’s disease mouse model
by: Yujie Ding, et al.
Published: (2021-03-01)